Piyavate Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2005
NCT00127309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Piyavate Hospital

Active Ingredients

Drugs in Other Trials (2)

gabapentin (neurontin) (1 trial)

glutathione (Furadantin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2